Rationale for IL-37 as a novel therapeutic agent in inflammation
Claudia A. Nold‐Petry, Marcel F. Nold
Abstract
KEYWORDS: Acute inflammationanti-inflammatory treatmentchronic inflammationcytokinedisease mechanismsimmunologyinterleukin 37novel therapeutictranslational research
Topics & Concepts
MedicineInflammationIntensive care medicineImmunologyIL-33, ST2, and ILC PathwaysPsoriasis: Treatment and PathogenesisAsthma and respiratory diseases